News
Latest News and Press Releases
Discussions Begin on Collaborative Genomic Drug Discovery Support Using the IQVIA Genome Wide Study Platform
Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa, Kanagawa; President and CEO: Nobuhiko Yamada; hereinafter, “Axcelead DDP”) and...
BIO International Convention 2023: Meet us in Boston
Axcelead will be exhibiting at upcoming BIO International Convention 2023 in Boston. Visit us at Japan Pavilion...
Luncheon seminar at the 43rd Workshop of the Korean Society of Nonclinical Study
Join us for our luncheon seminar and visit us at booth #8 during the 43rd Workshop of...
Interview with Ikeura, President and CEO of Axcelead, a holding company, was published in “PHARMA JAPAN”. 『Axcelead to Expand Overseas Biz, Shoots for 130 Billion Yen Sales and 5,000-Plus Researchers』
As a global CRDMO (Contract Research, Development and Manufacturing Organization), Axelead, a holding company, will be fully...
Change of President & CEO
Kanagawa, Japan, April 13, 2023 — We announced that it has decided to make the following changes...